Answer
Ledipasvir/Sofosbuvir Gilead should not be used during breastfeeding because human milk excretion is unknown, animal data show milk excretion of ledipasvir and sofosbuvir metabolites, and risk to newborns or infants cannot be excluded; if ribavirin is co-administered, its breastfeeding contraindications also apply.
Sources for this answer
- Ledipasvir/Sofosbuvir Gilead 90 mg/400 mg film-coated tabletsGilead Sciences Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 6Document updated
Sources checked